ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AATG Albion Technology & General Vct Plc

67.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Albion Technology & General Vct Plc LSE:AATG London Ordinary Share GB0005581672 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 67.50 66.00 69.00 67.50 67.50 67.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investors, Nec -2.85M -6.3M -0.0330 -20.45 128.78M

Directorate change

01/09/2023 11:15am

GlobeNewswire Inc.


Albion Technology & Gene... (LSE:AATG)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Albion Technology & Gene... Charts.
Directorate change

ALBION TECHNOLGY & GENERAL VCT PLC

DIRECTORATE CHANGE

LEI Code 213800TKJUY376H3KN16

As part of its succession planning and in accordance with LR 9.6, the Board of Albion Technology & General VCT PLC (the “Company”) is delighted to announce the appointment of Peter Moorhouse as a non-executive Director of the Company with effect from 1 September 2023. Peter will also become a member of the Audit & Risk, Remuneration, Nomination and Management Engagement Committees.

Peter has extensive corporate finance experience of advising boards and management teams in the UK, Europe and US, particularly on equity financing and mergers and acquisitions, with specialisations in the healthcare and technology sectors. He also has valuable experience of private equity investment, including early-stage financing, strategic development, IPOs and exits. Peter’s most recent role was as a Managing Director and Senior Advisor in Morgan Stanley’s investment banking business, principally advising companies in the healthcare, pharmaceutical and biotech sectors. Prior to this, Peter was a Managing Director at Merrill Lynch, having started his corporate finance career at Smith New Court.

Peter will stand for election at the Annual General Meeting of the Company to be held in 2024.

The Board welcomes Peter and looks forward to working with him over the coming years.

Clive Richardson, Chairman1 September 2023

For further information please contact:

Vikash HansraniOperations PartnerAlbion Capital Group LLPTel: 020 7601 1850

1 Year Albion Technology & Gene... Chart

1 Year Albion Technology & Gene... Chart

1 Month Albion Technology & Gene... Chart

1 Month Albion Technology & Gene... Chart